GeM Registration
Login
Support:
7202092200
Sales:
9904990022
/
9687177333
Support:
7202092200
Sales:
9904990022
/
9687177333
Indian Tenders
Global Tenders
Tender Results
GeM Tenders
Register
Pay Now
GeM Registration
Login
Indian
Awarded
Global
Advance Search
Keyword
Word Search
search
Classic Tenders
Indian Tenders
Keyword Tenders
L Asparaginase Injection
L Asparaginase Injection Tenders
Get complete information related to latest
L Asparaginase Injection Tenders
. from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic
L Asparaginase Injection Tenders
, private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding
L Asparaginase Injection Tenders
.
Filter
By Cities
Loading....
By States
Loading....
By Agencies
Loading....
By Ownerships
Loading....
By Sectors
Loading....
Bid Submission Date Range
Only MM/dd/yyyy format allowed.
Only MM/dd/yyyy format allowed.
Tender Value
search
reset
All-Tenders (2)
Fresh-Tenders
Live-Tenders
Archive-Tenders
Search
Get Tender in Email
CTN :42539792
27 Feb, 2026
NA
Mumbai
-
Maharashtra
Tender For corrigendum : supp
l
y of sch iii (supp
l
y of creams, drops, ointments, ora
l
l
iquids,
l
otions, syrups,
l
iniments, spiritious preparations & misce
l
l
aneous medicines etc.) - sch iii (supp
l
y of creams, drops, ointments, ora
l
l
iquids,
l
otions, syrups,
l
iniments, spiritious preparations & misce
l
l
aneous medicines etc.), eye drops containing ch
l
oramphenico
l
0.5%, eye drops containing f
l
uconazo
l
e 0.3%, eye drops containing gatif
l
oxacin 0.3%, eye drops containing ketoro
l
ac 0.5%, eye drops containing natamycin 5%, eye drops containing pi
l
ocarpine 2%, eye drops containing pheny
l
ephrine hydroch
l
oride u.s.p.10%, eye drops containing povidone iodine 5%, eye drops containing potasium iodide 3.3% with sodium ch
l
oride 0.83% with ca
l
cium ch
l
oride 1.3%, eye drops containing tropicamide 1%, eye drops containing homatropine 2%, eye ointment atropine su
l
phate 1% w/w, eye ointment containing acyc
l
ovir 3%, eye ointment containing neomycin su
l
phate 0.5% w/w, eye app
l
icaps of 250 mg containing ch
l
oramphenico
l
1% w/w, ear drops containing c
l
otrimazo
l
e 1% &
l
ignocaine hydroch
l
oride 2% + gentamycin 0.3% bec
l
omethasone 0.025%, ear drops containing bec
l
omethasone 0.025% +ch
l
oramphenico
l
1% + c
l
otrimazo
l
e 1% +
l
ignocaine 2%, eye/ear drops containing ciprof
l
oxacin hydroch
l
oride 0.3 %, ear/eye drops containing gentamycin su
l
phate 0.30%, eye/ear drops containing betamethasone sa
l
t 0.1% or dexamethasone sa
l
t 0.1% & neomycin su
l
phate 0.5 % w/v, eye/ear drops containing dexamethasone sa
l
t 0.1% or betamethasone sa
l
t 0.1%, antia
l
ergic nasa
l
spray bec
l
amethasone nasa
l
spray 50 mcg/spray, sa
l
butamo
l
nebu
l
ising so
l
ution 5 mg/m
l
.,
l
ignocaine hydroch
l
oride spray topica
l
10 % aeroso
l
pump spray for anaesthesia of mucosa 10 mg/puff, cream containing c
l
obetasone butyrate 0.05%, cream containing framycetin su
l
phate 1% w / w, cream containing si
l
ver su
l
phadiazine 1% (steri
l
e), sa
l
icy
l
ic acid ip 6.0% w/w ointment base qs, sa
l
icy
l
ic acid ip 12% w/w ointment base qs, ge
l
containing heparin for
l
.a 200 i.u/gm,
l
ignocaine hydroch
l
oride je
l
l
y 2% (steri
l
e), steri
l
ized non greasy a
l
l
purpose
l
ubricant je
l
l
y, tincture benzoin,
l
ignocaine hydroch
l
oride topica
l
so
l
ution 4 % steri
l
e.not for
injection
, rabeprazo
l
e sodium powder for ora
l
suspension sodium bicarbonate as buffer containing rabeprazo
l
e ip 20mg, dry syrup containing artemether 40 mg and
l
umefantrine 240 mg in 5 m
l
, syrup containing amoxyci
l
l
in 125mg/5m
l
, syrup containing ch
l
oroquine each 5 m
l
containing ch
l
oroquine phosphate ip 80 mg equiva
l
ent to 50mg of ch
l
oroquine base, syrup containing c
l
oxaci
l
l
in 125 mg/5m
l
, syrup containing codeine phosphate, syrup containing erythromycin 125 mg / 5 m
l
., syrup containing isoniazid 100 mg/5 m
l
. with/ without vit b6, syrup containing nitazoxanide 100mg/5m
l
, syrup containing na
l
idixic acid 300 mg./ 5 m
l
., syrup containing predniso
l
one 5 mg/5 m
l
. a
l
choho
l
free, syrup containing phenobarbitone 20mg/5m
l
, syrup containing pyrazinamide 250mg/5m
l
, syrup containing rifampicin 100 mg/5 m
l
, e
l
ixir containing digoxin 50 mcg/m
l
l
east content of a
l
choho
l
, suspension containing ibuprofen 100 mg/ 5m
l
, suspension containing trimethoprim 40 mg & su
l
phamethoxazo
l
e 200mg / 5 m
l
, ora
l
suspension containing each 1m
l
of the reconstituted suspension contains ose
l
tamivir phosphate ip equiva
l
ent to ose
l
tamivir 12 mg, syrup to
l
u, caffeine citrate steri
l
e ora
l
so
l
ution containing caffeine base 20 mg/m
l
, human mi
l
k fortifier each sachet containing protein -min 0.2 g ca
l
ories min 3 ca
l
, ca
l
cium min 15 mg, phosphorus min 7.5 mg , vitamin d - 3 mcg min., mu
l
tivitamin drops containing mu
l
tivitamin, mu
l
itiminera
l
and
l
ysine, feracry
l
um 1% w/w ge
l
, so
l
ution containg ferycy
l
um 1%w/v, ointment containing benzy
l
nicotinate 2 mg + heparin 50 iu for
l
a, ca
l
cipotrio
l
0.005% w/w cream, permethrin (5% w/w)
l
otion/rinse, hydroxyzine hydroch
l
oride 10mg/5m
l
, ch
l
orhexidine g
l
uconate so
l
0.2% mouthwash, eberconazo
l
e cream 1% w/w,, po
l
yethye
l
ene g
l
yco
l
400 ph. eur. - 0.4% w/v, propy
l
ene g
l
yco
l
ph.eur 0.3% w/v, hydroxypr
View Detail
Bid Tender
Download Document
Select Tender
CTN :43794355
25 Feb, 2026
NA
Haldwani
-
Uttarakhand
Tender For corrigendum : supp
l
y of medicine and iv f
l
uids - dextrose 5% inj ffs, dextrose 5% g
l
ass bott
l
e inj, dextrose 10% inj ffs, dextrose 25% inj ffs, sodium ch
l
oride inj 0.45% ffs, sodium ch
l
oride inj 0.9% ffs, sodium ch
l
oride inj 0.9% g
l
ass bott
l
e, 3% hypertonic sa
l
ine inj ffs, sodium ch
l
oride 0.9 % and dextrose 5gm inj ffs, compound ringer
l
actate inj, mu
l
tip
l
e e
l
ectro
l
ytes & dextrose
injection
type i ip (e
l
ectro
l
yte p
injection
) ffs, 6% hydroxyethy
l
starch so
l
ution inj ffs/pouch, mu
l
tipi
l
e e
l
ectro
l
yte so
l
ution (crysto
l
l
ide so
l
for p
l
asma rep
l
acement) inj type 1 ffs/pouch, mannito
l
ip 20% inj, mannito
l
ip 10% & g
l
ycerine 10% inj, sodium bicarbonate inj 8.4% w/v, potassium ch
l
oride inj 15mg/1m
l
, cefpodoxime 200 mg potassium c
l
avu
l
anate 125 mg cap/tab,
l
inezo
l
id 600 mg cap/tab, amoxyci
l
l
in potassium c
l
avu
l
anate 500 mg + c
l
avu
l
anic acid 125 mg +
l
actobaci
l
l
us 60 mi
l
l
ion spores cap, rifaximin 400 mg cap/tab, cefixime 100mg/5m
l
ora
l
suspension, doxycyc
l
ine 100 mg/via
l
inj,
l
evof
l
oxacin 500mg/100 m
l
inj, ciprof
l
oxacin inj 200 mg/100 m
l
ffs, moxif
l
oxacin inj 400mg/100 m
l
ffs, vancomycin 500 mg/via
l
inj,
l
inezo
l
id 600mg/300m
l
inj, minocyc
l
ine 100 mg inj, teicop
l
anin 400 mg inj, povidone iodine c
l
eansing scrub 7.5% so
l
ution, g
l
utara
l
dehyde 2.4% so
l
ution, cetrimide 3% w/v ch
l
orhexidine 1.5% w/v, si
l
ver su
l
phadiazine 10mg/gm cream, framycetin su
l
phate 1% w/w cream,
l
ansoprazo
l
e ora
l
l
y disintegrating 15 mg tab, rabeprazo
l
e 20 mg domperidone 30 mg sr tab, pantoprazo
l
e 40 mg inj,
l
actu
l
ose syp 10gm/15m
l
, po
l
yethy
l
ene g
l
yco
l
13.125mg/25m
l
+ sodium ch
l
oride 350.7 mg/25m
l
+ sodium bicarbonate 178.5 mg/25 m
l
+ potassium ch
l
oride 46.6 mg/25 m
l
, bisacody
l
5mg tab, metoc
l
opramide inj 10mg/2m
l
, ondansetron inj 2mg/m
l
, doxy
l
amine 10mg + pyridoxine 10 mg tab, ondensetron 2mg/5m
l
syrup, metronidazo
l
e
injection
500 mg/ 100m
l
ffs, spores of po
l
y antibiotic resistant baci
l
l
us c
l
ausii 2 bi
l
l
ion/5 m
l
, etofy
l
l
ine 84.7 mg/m
l
& theophy
l
l
ine 25.3 mg/m
l
inj, sa
l
butamo
l
su
l
p. 2.5mg/2.5m
l
in norma
l
sa
l
ine respirator so
l
., budesonide 1mg/2m
l
steroid nebu
l
izing susp., ipratropium ip 500 mcg/2.5 m
l
l
evosa
l
butamo
l
1.25 mg/2.5 m
l
respirator so
l
., formotero
l
20 mcg/ 2m
l
budesonide 0.5 mg/ 2m
l
respirator susp., g
l
ycopyrronium 25 mcg/2m
l
inha
l
ation so
l
., n acety
l
cysteine 200mg/m
l
inha
l
ation so
l
., nitrog
l
ycerine contro
l
l
ed re
l
ease 2.6 mg tab, metopro
l
o
l
25 mg extended re
l
ease tab,
l
abeta
l
o
l
100 mg tab,
l
abeta
l
o
l
inj 5mg/m
l
, ci
l
nidipine 10 mg tab, ci
l
nidipine 10 mg + te
l
misartan 40 mg tab, amiodarone hydroch
l
oride ip 50 mg/m
l
inj, dopamine 40 mg/m
l
inj, dobutamine 50mg/m
l
inj, noradrena
l
ine 1mg/m
l
inj, adrena
l
ine 1mg/m
l
inj, acetazo
l
amide 250 mg tab, torsemide 10 mg tab, etamsy
l
ate 250 mg + tranexamic acid 500 mg tab, tranxemic acid inj 500mg/5m
l
, aqueous so
l
ution of haemocoagu
l
ase iso
l
ated from venom of bothrops jararaca 1cu/m
l
, aqueous so
l
ution of haemocoagu
l
ase iso
l
ated from bothrops atrox or bothrops jararaca 0.2cu/m
l
topica
l
so
l
ution, heparin sodium 5000 iu/m
l
inj, heparin sodium 50 iu/gm ge
l
, tramado
l
inj 100mg/2 m
l
, paracetamo
l
250mg/5m
l
ora
l
suspension, paracetamo
l
inj infusion 1000mg/100m
l
ffs, dic
l
ofenac sodium 75mg/m
l
iv (aques) inj, each enteric-coated tab
l
et contains 1,00,000 armour units of enzymatic activity. supp
l
ied by a purified concentrate which has specific trypsin and chymotrypsin activity in a ratio of approximate
l
y six to one., naproxen 500 mg tab, phenytoin inj 100mg/2m
l
, sodium va
l
proate inj 100mg/m
l
, pheniramine ma
l
eate 22.75mg/m
l
inj, fexofenadine hc
l
120 mg + monte
l
ukast 10 mg tab, def
l
azacort 6 mg tab, methy
l
predniso
l
one sodium succinate 250 mg inj, dexamethasone inj 8mg/2m
l
, hydrocortisone inj 100mg/via
l
,
l
ignocaine hydroch
l
oride 21.3 mg/m
l
, sodium ch
l
oride 6.0 mg/m
l
inj,
l
ignocaine hydroch
l
oride 21.3mg/m
l
with adrena
l
ine 0.005mg/m
l
inj,
l
ignocaine 2% je
l
l
y,
l
ignocaine without preservative (each m
l
contain
l
ignocaine hydroch
l
oride 21.3 mg, sodium ch
l
oride 6.0 mg) inj, bupivacaine hydroch
l
oride 5 mg/m
l
(heavy), dextrose 80 mg/m
l
inj, b
View Detail
Bid Tender
Download Document
Select Tender
Loading, Please wait...
View More
×
Tender Document
Select State
Select City
023053
Get the Tenders in eMail
(Select any tender from the list)
×
Download Mobile App
×